# Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis

> **NCT06228781** · NA · NOT_YET_RECRUITING · sponsor: **Tianjin Medical University General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **PROCEDURE:** Autologous haemopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT06228781
- **Lead sponsor:** Tianjin Medical University General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06228781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06228781, "Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06228781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*